Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-altitude effect on remifentanil-induced hyperalgesia after general anesthesia
ChiCTR2100050297Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remifentanil and sufentanil in postoperative pain and opioid-induced hyperalgesia (OIH) (4 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Hyperalgesia, Dosage of self-controlled analgesics and 1 more. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
remifentanilsufentanil
03
Conditions
postoperative painopioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on ChiCTR2100050297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050297.